| 中文名称 | 替诺昔康 |
| 英文名称 | Tenoxicam |
| CAS号 | 59804-37-4 |
| 分子式 | C13H11N3O4S2 |
| 分子量 | 337.37 |
| EINECS号 | 620-500-8 |
| 熔点 | 209-2130C (dec) |
| 密度 | 1.4737 (rough estimate) |
| 折射率 | 1.6390 (estimate) |
| 溶解度 | 几乎不溶于水,微溶于二氯甲烷,极微溶于无水乙醇。溶于酸和碱溶液。 |
| 形态 | 固体 |
| 酸度系数(pKa) | pKa1 5.3, pKa2 1.1(at 25℃) |
| 颜色 | 白色到黄色到绿色 |
| 水溶解性 | 61.9mg/L(32 ºC) |
| 危险品标志 | T,Xi |
| 危险类别码 | 23/24/25-36/37/38 |
| 安全说明 | 36/37/39-45-36-26-36/37 |
| 危险品运输编号 | UN 2811 6.1/PG 3 |
| WGK Germany | 2 |
| RTECS号 | XJ9095060 |
| 海关编码 | 2934.99.3000 |
| 危险等级 | 6.1 |
|
COX-1
|
COX-2
|
Tenoxicam (Ro-12-0068) is a non-steroidal anti-inflammatory drug (NSAID).
Tenoxicam (Ro-12-0068) was administered intraperitoneally immediately after BCAO. Histological analyses show that ischemia produced significant striatal as well as hippocampal lesions which were reversed by the Tenoxicam (Ro-12-0068) treatment. Tenoxicam (Ro-12-0068) also significantly reduced, to control levels, the increased myeloperoxidase activity in hippocampus homogenates observed after ischemia.